Cryoablation Or Brachytherapy? Endocare Promotes Prostate First-Line Option
This article was originally published in The Gray Sheet
Executive Summary
Endocare is hoping that the results of an eight-year 590-patient registry study will convince more urologists to use cryoablation as an alternative to brachytherapy for first-line treatment of prostate cancer